Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

shutterstock_36423250

Summit Pharma axes Duchenne drug after Phase 2 failures

June 28, 2018 Research and Development Duchenne Muscular Dystrophy, Summit Pharmaceuticals, pharma, trial failure

Summit Therapeutics has revealed it is to terminate development of its Duchenne muscular dystrophy (DMD) drug ezutromid after it failed …
News
amgen_hq

Amgen biosimilar proves non-inferior to J&J’s Remicade in rheumatoid arthritis

June 27, 2018 Research and Development, Sales and Marketing Amgen, Johnson & Jonson, Remicade, pharma, rheumatoid arthritis

Amgen has unveiled new Phase 3 data for its biosimilar version of Johnson & Johnson’s Remicade (infliximab), confirming that it …
News
shutterstock_95714119

US hospital’s ketamine study forced to a halt over consent concerns

June 27, 2018 Research and Development Hennepin Healthcare, Ketamine, pharma

Minneapolis-based hospital Hennepin County Medical Center has put the brakes on a clinical trial investigating the efficacy of ketamine in …
News
abbvie_0

Abbvie and Google’s Calico extend age-related disease partnership to $2.5bn

June 27, 2018 Research and Development, Sales and Marketing AbbVie, Cancer, Goggle, calico, pharma

The partnership of Abbvie and Google’s Calico has announced they are to extend their existing 10-year drug discovery and development …
News
astrazeneca_building_white

AstraZeneca’s Lynparza proves efficacy in first-line BRCA-mutated advanced ovarian cancer

June 27, 2018 Research and Development, Sales and Marketing AstraZeneca, Cancer, MSD, Merck, ovarian cancer, pharma

AstraZeneca is celebrating alongside partner MSD with the reveal of new data on the use of Lynparza in the first-line …
News
fdaoutsideweb

FDA panels vote to reject Pain Therapeutics’ abuse-deterrent opioid drug

June 27, 2018 Research and Development, Sales and Marketing Remoxy, opioid crisis, opioids, pain therapeutics, pharma

Drug development firm Pain Therapeutics has revealed that its abuse-deterrent opioid medication Remoxy has been rejected by an FDA advisory …
News
image_credit_roivant

Roivant launches two new companies amid major restructure and staff layoffs

June 26, 2018 Manufacturing and Production, Research and Development Roivant, pharma

Roivant, the global biopharmaceutical firm spearheaded by founder and CEO Vivek Ramaswamy (pictured), has announced it is to undergo a …
News
pfizerbrussels_web

Pfizer’s Ibrance combo fails to improve overall survival in HER2- metastatic breast cancer

June 26, 2018 Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Faslodex, Pfizer, breast cancer, ibrance, pharma

Pfizer has stumbled with the reveal of new data on the efficacy of its oral CDK 4/6 inhibitor Ibrance (palbociclib) in combination …
News

Sanofi’s Toujeo proves non-inferior to insulin degludec in type 2 diabetes

June 26, 2018 Manufacturing and Production, Research and Development, Sales and Marketing American Diabetes Association, Sanofi, diabetes, insulin glargine, pharma, toujeo, type 2 diabetes

Sanofi took the opportunity at the American Diabetes Association (ADA) 78th Scientific Sessions in Florida to unveil new data on …
News
si_lem_new_photo_171118

Working Life: Vertex Pharma’s Simon Lem, VP, Regional General Manager of North Europe

June 25, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Vertex, Vertex pahrma, Working Life, feature, pharma

Pharmafocus caught up with Vertex Pharma’s Simon Lem to discuss his journey throughout the industry and the importance of the …
Feature
shutterstock_349943306

Sophiris halts cancer study after patient death

June 25, 2018 Research and Development, Sales and Marketing Cancer, Sophiris, pharma, prostate cancer

Another clinical trial has been forced to a standstill as biotech firm Sophiris revealed that a patient death had prompted …
News
lilly_entrance_web

Eli Lilly’s dulaglutide doses show blood control and weight benefits at Phase 2

June 25, 2018 Research and Development, Sales and Marketing Eli Lilly, Trulicity, diabetes, pharma

Eli Lilly has announced new data on its once-weekly, injectable glucagon-like peptide Trulicity (dulaglutide 1.5mg) and investigational 3.0 and 4.5mg …
News
roche__tree

Roche’s Tecentriq combo extends life in untreated lung cancer

June 25, 2018 Research and Development, Sales and Marketing Cancer, Roche, lung cancer, pharma, tecentriq

Roche has unveiled new data on the efficacy of Tecentriq (atezolizumab) in combination with chemotherapy (carboplatin and etoposide) for the …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

June 22, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, top ten

The sun is out in the UK, it’s Friday, and the July/August issue of Pharmafocus is going to print. And, …
News
shutterstock_141299494

Elderly cancer cases to increase 80% by 2035, says CRUK

June 21, 2018 Medical Communications, Research and Development CRUK, Cancer, Cancer Research UK, NHS, UK, pharma

A new report from Cancer Research UK has indicated that the number of UK  citizens over the age of 75 …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026